A Comparison of Esmolol and Remifentanil to Reduce Blood Loss

Clinical trial NCT01752959 · UNKNOWN

Trial details

NCT number: NCT01752959
Sponsor: Diskapi Teaching and Research Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Deviation Septum Nasal

Start date: 2012-07-01
Primary completion: 2012-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.